Sigma2 (σ2) receptors as a target for cocaine action in the rat striatum

European Journal of Pharmacology

Volumn 535, Issue 1-3, 2006, Pages 98-103

  Nuwayhid, Samer J ^a   Werling, Linda L ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

receptor; Cocaine; Dopamine release; Dopamine transporter; Protein kinase C

Indexed keywords

1' [4 [1 (4 FLUOROPHENYL) 1H INDOL 3 YL] 1 BUTYL] SPIRO[ISOBENZOFURAN 1 (3H), 4 PIPERIDINE]; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 [1 [3 (DIMETHYLAMINO)PROPYL 1H INDOLE 3 YL] 1 H PYRROL 2,5' DIONE; COCAINE; DOPAMINE TRANSPORTER; LY 379196; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID; NOMIFENSINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RECEPTOR BLOCKING AGENT; SIGMA 1 OPIATE RECEPTOR; THAPSIGARGIN; UNCLASSIFIED DRUG; 1 CYCLOPROPYLMETHYL 4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERIDINE; 5,21 - 12,17-DIMETHENEO-18H-DIBENZO(I,O)PYRROLO(3,4-1)(1,8)DIAZACYCLOHEXANDECINE-18,10(19H)DIONE,8((DIMETHYLAMINO)METHYL)-6,7,8,9,10,11-HEXAHYDRO,MONOMETHANESULFONATE; 5,21 12,17 DIMETHENEO 18H DIBENZO(I,O)PYRROLO(3,4 1)(1,8)DIAZACYCLOHEXANDECINE 18,10(19H)DIONE,8((DIMETHYLAMINO)METHYL) 6,7,8,9,10,11 HEXAHYDRO,MONOMETHANESULFONATE; BENZYLAMINE DERIVATIVE; BISINDOLYLMALEIMIDE I; CALCIUM; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; ENZYME INHIBITOR; INDOLE DERIVATIVE; LU 28 179; LU 28-179; MALEIMIDE DERIVATIVE; MESYLIC ACID DERIVATIVE; N METHYLASPARTIC ACID; PENTAZOCINE; PIPERIDINE DERIVATIVE; PYRROLE DERIVATIVE; SIGMA 2 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR; SIGMA-2 RECEPTOR; SPIRO COMPOUND; SULFONAMIDE; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; LIMBIC CORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; MALE; METABOLISM; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALS; BENZYLAMINES; CALCIUM; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INDOLES; MALE; MALEIMIDES; MESYLATES; N-METHYLASPARTATE; NOMIFENSINE; PENTAZOCINE; PIPERIDINES; PROTEIN KINASE C; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; SPIRO COMPOUNDS; SULFONAMIDES; TRITIUM;

EID: 33645405577     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.077     Document Type: Article

References (27)

1. J.W. Barclay, A. Morgan, and R.D. Burgoyne Calcium-dependent regulation of exocytosis Cell Calcium 38 2005 343 353
2. 2+ release J. Biol. Chem. 270 1995 7257 7260
3. 2 receptor regulation of DAT activity via protein kinase C J. Pharm. Exp. Ther. 301 2002 306 314
4. l transduction pathways, inhibitors, and agents in development Curr. Med. Chem. 6 1999 877 903
5. 3H]dopamine release from rat striatal slices by sigma receptor ligands J. Pharmacol. Exp. Ther. 271 1994 212 219
6. 1 receptors Proc. Natl Acad. Sci. U. S. A. 98 2001 491 496
7. 2+ concentration J. Pharmacol. Exp. Ther. 293 2000 788 798
8. B.K. Koe Molecular Geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain J. Pharmacol. Exp. Ther. 199 1976 649 661
9. K.Y. Little, D.M. Krolewski, L. Zhang, and B.J. Casin Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users Am. J. Psychiatry 160 2003 47 55
10. D.C. Mash, J. Pablo, Q. Ouyang, W.L. Hearn, and S. Izenwasser Dopamine transport function is elevated in cocaine users J. Neurochem. 81 2002 292 300
11. R.R. Matsumoto, K.L. Hewett, B. Pouw, W.D. Bowen, S.M. Husbands, J.J. Cao, and A. Hauck Newman Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters Neuropharmacology 41 2001 878 886
12. R.R. Matsumoto, D.L. Gilmore, B. Pouw, W.D. Bowen, W. Williams, A. Kausar, and A. Coop Novel analogs of the sigma receptor ligand BD1008 attenuate cocaine-induced toxicity in mice Eur. J. Pharmacol. 492 2004 21 26
13. 1 receptor antagonists represent a new strategy against cocaine addiction and toxicity Neurosci. Biobehav. Rev. 26 2002 499 527
14. 2 binding site: spiro-joined benzofuran, isobenzofuran and benzopyran piperidines J. Med. Chem. 38 1995 2009 2017
15. M. Novakova, C. Ela, W.D. Bowen, Y. Hasin, and Y. Eilam Highly selective sigma receptors elevate inositol 1,4,5-triphosphate production in rat cardiac myocytes Eur. J. Pharmacol. 353 1998 315 327
16. 1 receptor agonist-mediated regulation of N-methyl-d-aspartate-stimulated release is dependent upon protein kinase C J. Pharmacol. Exp. Ther. 304 2003 364 369
17. T. Oda, M.S. Shearman, and Y. Nishizuka Synaptosomal protein kinase C subspecies: beta downregulation promoted by phorbol ester and its effects on evoked norepinephrine release J. Neurochem. 56 1991 1263 1269
18. B.A. Rocha, F. Fumagalli, R.R. Gainetdinov, S.R. Jones, R. Ator, B. Giros, G.W. Miller, and M.G. Caron Cocaine self-administration in dopamine-transporter knockout mice Nat. Neurosci. 1 1998 132 137
19. 2-ligand Lu28-179 has potent anxiolytic-like effects in rodents J. Pharmacol. Exp. Ther. 283 1997 1323 1332
20. S.W. Tam, G.F. Steinfels, P.J. Gilligan, W.K. Schmidt, and L. Cook DuP734 [1-(cyclopropylmethyl)-4-(2(4″-fluorophenyl)-2(-oxoethyl)-piperidine HBr] a sigma and 5HT2 receptor antagonist: receptor binding, electrophysiology and neuropharmacological profiles J. Pharmacol. Exp. Ther. 263 1992 1167 1174
21. T.L. Thompson, S. Bridges, and C. Miller Modulation of dopamine uptake in rat nucleus accumbens: effect of specific dopamine receptor antagonists and sigma ligands Neurosci. Lett. 312 2001 169 172
22. B.J. Vilner, and W.D. Bowen Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in SK-N-SH neuroblastoma cells J. Pharmacol. Exp. Ther. 292 2000 900 911
23. K.J. Way, E. Chou, and G.L. King Identification of PKC-isoform-specific biological actions using pharmacological approaches Trends Pharmacol. Sci. 21 2000 181 187
24. 3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma-2 receptors J. Pharmacol. Exp. Ther. 289 1999 278 284
25. L.L. Werling, A. Frattali, P.S. Potoghese, A.E. Takemori, and B.M. Cox Kappa receptor regulation of dopamine release from striatum and cortex of rat and guinea pig J. Pharmacol. Exp. Ther. 247 1988 1103 1106
26. L.L. Werling, P.N. McMahon, and B.M. Cox Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices Naunyn-Schmiedeberg's Arch. Pharmacol. 339 1989 509 513
27. L.L. Werling, P.J. Hoehner, K.J. Hurt, L.G. Fox, T.J.J. Blanck, R.E. Rosenthal, and G. Fiskum Increased activation of L-type voltage-dependent calcium channels is associated with Glycine enhancement of N-methyl-d-aspartate- stimulated dopamine release in global cerebral ischemia/reperfusion J. Neurochem. 63 1994 215 221